Investor’s Watch List: Gilead Sciences (NASDAQ:GILD), Consolidated Communications Holdings (NASDAQ:CNSL), GT Advanced Technologies Inc (NASDAQ:GTAT), Novartis (NYSE:NVS)

FB Nasdaq FB Facebook

Gilead Sciences, Inc. (NASDAQ:GILD) company on Mar. 28 announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for conversion on or after February 1, 2014 entirely in cash. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.92% in last session and finished the day at $73.64. Traded volume was 19,465,500 million shares in the last session and the average volume of the stock remained 13.39 million shares. The beta of the stock remained 0.60. Gilead Sciences, Inc. (NASDAQ:GILD) insider ownership is 0.50%.

Consolidated Communications, Inc. (NASDAQ:CNSL) announced that effective today, it will begin doing business in its SureWest markets under the “Consolidated Communications” name and brand. Consolidated Communications Holdings Inc (NASDAQ:CNSL) rose 0.95 percent to $20.20 yesterday on volume of 232.54 million shares. The intra-day range of the stock was $19.80 to $20.35. Consolidated Communications Holdings Inc (NASDAQ:CNSL) has a market capitalization of $813.17 million.

Goldman Sachs maintained a Buy rating on GT Advanced Tech (NASDAQ:GTAT). GT Advanced Technologies Inc (NASDAQ:GTAT)’s stock on April 1, 2014 reported an increase of 1.94% to the closing price of $17.38. Its fifty two weeks range is $3.03 -$19.44. The total market capitalization recorded $2.34 billion. The overall volume in the last trading session was 6,741,200 million shares. In its share capital, GT Advanced Technologies Inc (NASDAQ:GTAT) has 134.46 million outstanding shares.

Novartis A.G. (ADR) (NYSE:NVS) and worldwide collaborators published results of their Phase I clinical trial of the ALK inhibitor Ceritinib (LDK378) in the New England Journal of Medicine on March 27. On Tuesday, shares of Novartis AG (ADR) (NYSE:NVS) dropped -0.60% to close the day at $84.51. Company return on investment (ROI) is 10.20% and its monthly performance is recorded as 3.96%. Novartis AG (ADR) (NYSE:NVS) quarterly revenue growth is 8.74%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone